Influenza and Pneumococcal Vaccines

U.S. Surgeon General Teams With Major Medical Groups to Urge Priority Influenza & Pneumococcal Vaccination for High-Risk Groups

National Press Club, 13th floor, Washington, DC
Wednesday, October 25, 2000 at 10:00 am ET
Presented by:
The National Foundation for Infectious Diseases and
The National Coalition for Adult Immunization

In Collaboration With:

Centers for Disease Control and Prevention (CDC), Health Care Financing Administration (HCFA), American College of Physicians-American Society of Internal Medicine (ACP-ASIM), National Medical Association (NMA)

10:00 a.m.

Introduction and Welcome
William J. Martone, MD, senior executive director, NFID
Steven Mostow, M.D., NFID board of directors, University of Colorado Health Sciences Center

10:03 a.m.

Surgeon General Issues Plea for Responsible Vaccination
David Satcher, M.D., Ph.D., U.S. surgeon general and assistant secretary, Public Health and Science, Department of Health and Human Services

10:13 a.m.

High-Risk Groups for Influenza, Pneumococcal Disease
Kristin Nichol, M.D., M.P.H., chair, NCAI standing advisory committee; chief, medicine service, VA Medical Center, Minneapolis, Minnesota

10:23 a.m.

New CDC/ACIP Recommendations for Influenza and Pneumococcal Vaccination, 2000-2001 Season
Keiji Fukuda, M.D., M.P.H., epidemiology section chief, influenza branch, CDC

10:33 a.m.

Disparities by Population Segment
Bonnie Word, M.D., National Medical Association

10:43 a.m.

Physicians Urged to Improve Adult Vaccination Rates
Sandra Adamson Fryhofer, M.D., F.A.C.P., president, ACP-ASIM
Medicare Coverage for Influenza and Pneumococcal Vaccination
Jeffrey Kang, M.D., M.P.H., director of the office of clinical standards and quality, HCFA

10:50 a.m.

Questions and Answers
This press conference is supported, in part, by unrestricted educational grants to the National
Foundation for Infectious Diseases (NFID) and the National Coalition for Adult Immunization (NCAI) by Aventis Pasteur, Aviron, Health Care Financing Administration, Merck Vaccine Division and Wyeth Lederle Vaccines.